| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |